Invesaro

Stocks Health care BGMS

NASDAQ · Health care

Bio Green Med Solution, Inc. (BGMS)

It posted a net loss of $2.2M. At June 30, 2026 it held $3.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch BGMS in 60 seconds
Price
$0.90
-2.62% on the day · September 28, 2026
52-week range $0.57 to $6.70
Market cap
$6M

What Bio Green Med Solution, Inc. does

Bio Green Med Solution, Inc. is registered with the SEC under industry code SIC 5099 (Wholesale-Durable Goods, NEC). Its shares trade on NASDAQ under the ticker BGMS.

Revenue and profit by year

Revenue
FY18: $150K $150K FY18FY20: $0 $0 FY20FY21: $0 $0 FY21FY22: $0 $0 FY22FY23: $420K $420K FY23FY24: $43K $43K FY24FY25: $747K $747K FY25
Net income
FY18: -$7.3M -$7.3M FY18FY19: -$7.8M -$7.8M FY19FY20: -$8.4M -$8.4M FY20FY21: -$18.5M -$18.5M FY21FY22: -$21.2M -$21.2M FY22FY23: -$22.6M -$22.6M FY23FY24: -$11.2M -$11.2M FY24FY25: -$3M -$3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$747K-$8.4M-$3M-$6.45n/a
2024$43K-$12M-$11.2M-$502.46n/a
2023$420K-$25.5M-$22.6M-$6,419.18-$16.1M
2022$0-$27.7M-$21.2M-$27.24-$20.8M
2021$0-$22.4M-$18.5M-$2.09-$18.6M
2020$0-$10.6M-$8.4M-$3.42-$8M

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: about 92 days after its last report of August 14, 2026, its usual gap. Not a date the company has announced. See the report calendar

Where BGMS ranks in Health care

Revenue$747K
#658 of 742 in Health care · Bottom 11%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Bio Green Med Solution, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 11, 2026
  2. August 21, 2026
  3. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue was $336K; net loss of $405K.
  4. August 14, 2026
  5. August 12, 2026
  6. August 12, 2026
  7. July 24, 2026
  8. July 1, 2026
  9. June 22, 2026
  10. June 16, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 13, 2025. Insider transactions on SEC

Insider trades

What the people running Bio Green Med Solution, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
November 12, 2025 Kiu Cu SengChief Financial Officer, Director Received as pay 200,000 $1.40 $280K Form 4
November 12, 2025 Doris Wong Sing EeChief Executive Officer, Director, 10% owner Received as pay 300,178 $1.40 $420.2K Form 4
November 5, 2025 Ong Yee Lung10% owner Other change 467,535 - - Form 4
November 5, 2025 Yap Kim Choy10% owner Sold 28,540 $1.70 $48.5K Form 4
November 5, 2025 Yap Kim Choy10% owner Other change 467,535 - - Form 4
November 5, 2025 Kua Khai Loon10% owner Other change 467,535 - - Form 4
October 30, 2025 Ong Yee Lung10% owner Sold 248,814 $1.80 $447.9K Form 4
October 30, 2025 Kua Khai Loon10% owner Sold 242,477 $1.80 $436.5K Form 4
October 30, 2025 Yap Kim Choy10% owner Sold 112,260 $1.81 $202.9K Form 4
October 29, 2025 Yap Kim Choy10% owner Sold 110,749 $1.83 $203.1K Form 4
October 28, 2025 Yap Kim Choy10% owner Sold 13,111 $1.83 $24K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BGMS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Doris Wong Sing Ee13D, may seek influence 20.58% 1,111,131 November 13, 2025

Latest filings below 5%: FITTERS Diversified Berhad 0% (August 12, 2026); Yap Kim Choy 0% (August 12, 2026); Ong Yee Lung 0% (March 13, 2026); Kua Khai Loon 0% (March 13, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

5 insiders reported holding 2,713,736 shares in total, about $2.5M at the last price.

HolderSharesAs of
Doris Wong Sing EeChief Executive Officer, Director, 10% owner 1,111,131 November 12, 2025
Ong Yee Lung10% owner 467,535 November 5, 2025
Yap Kim Choy10% owner 467,535 November 5, 2025
Kua Khai Loon10% owner 467,535 November 5, 2025
Kiu Cu SengChief Financial Officer, Director 200,000 November 12, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BGMS

What does Bio Green Med Solution, Inc. do?

Bio Green Med Solution, Inc. is registered with the SEC under industry code SIC 5099 (Wholesale-Durable Goods, NEC). Its shares trade on NASDAQ under the ticker BGMS.

Is Bio Green Med Solution, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $2.2M.

When did Bio Green Med Solution, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the merger registration (amended) from September 11, 2026.

Similar companies

Compare BGMS with

Compare BGMS with any company

Follow BGMS

Get an email when Bio Green Med Solution, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow BGMS: get an email when it files

Where the numbers come from

Financial figures are the values Bio Green Med Solution, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.